What Can Be Mistaken for Ulcerative Colitis?

Several conditions can look like ulcerative colitis, and because there is no single test that proves UC, the diagnosis is assembled from symptoms, stool tests, colonoscopy and biopsies. The look-alikes that matter most are infections (including amoebiasis and sexually transmitted proctitis), Crohn's disease in the colon, colitis caused by medicines, and, in older adults, ischaemic colitis, diverticular colitis, microscopic colitis and bowel cancer. When a UC label does change, the most common new answer in the cohort studies is "not IBD at all", not a swap to Crohn's.

This article is for two kinds of reader. One is waiting for answers, or has just been told "it's probably colitis" after a first scope, and wants to know what else it could be. The other has lived with a UC diagnosis for years and has just met a doctor who doubts it. Both questions come up constantly on r/UlcerativeColitis and r/CrohnsDisease, and the pages that rank for them mostly offer a list of names with no numbers attached. Here are the numbers, the tests that separate the look-alikes, and what to do when two specialists disagree.

It is not a self-diagnosis tool. Nothing here can tell you which condition you have. It can help you understand why your team is ordering a particular test, and what to mention that might change their thinking.

The short answer: UC is a pattern, not a test result

Ulcerative colitis is diagnosed when a recognisable pattern comes together and the alternatives have been excluded. The European diagnostic guideline puts it plainly: "A single reference standard for the diagnosis of Crohn's disease (CD) or ulcerative colitis (UC) does not exist", and the diagnosis rests on a combination of clinical, biochemical, stool, endoscopic and histological investigations, with infectious colitis, including C. difficile, excluded (Maaser 2019).

The same guideline is equally direct about the colonoscopy itself: "No endoscopic feature is specific for CD or UC." The features that point towards UC are inflammation that starts in the rectum, runs continuously upwards, and stops with a clear edge. The features that point towards Crohn's are skip lesions, strictures, fistulas and perianal disease (Maaser 2019). "Points towards" is doing a lot of work in both sentences.

That is why the diagnosis is a pattern. Each piece is shared with something else:

• Bloody diarrhoea and urgency happen in infection, sexually transmitted proctitis, ischaemic colitis and cancer.
• Inflamed rectum and colon on the scope happen in infection, medicine-related colitis and Crohn's colitis.
• Raised calprotectin happens in any of the above, and with some medicines.
• Biopsy changes of chronic colitis are the strongest single clue, but they take time to develop and can fade with treatment.

So when people ask "what can be mistaken for UC?", the honest answer is anything that produces part of the pattern, at the moment the pattern is being assembled.

How often does a UC diagnosis turn out to be wrong?

Across the cohorts below, between about 2% and 14% of people with any IBD label saw it change during follow-up, depending on who was studied and for how long; for UC specifically, the figures cluster around 7% to 9%. The figure most people half-remember from forums, "about 10%", is in the right range, but the direction of the change is not what most people assume.

Three things stand out.

The biggest group is "not IBD at all". In both adult cohorts, more people lost an IBD diagnosis than switched between UC and Crohn's. In the Korean study, 135 of the 292 people eventually judged not to have IBD had already received IBD medication (Lee 2016). That is the real cost of a mimic: treatment for a disease you do not have, and the actual cause left untreated.

Referral centres see more changes. People sent to a specialist centre are, by definition, the ones whose story was not straightforward, so 13.8% should not be read as a general misdiagnosis rate. The population figure from Norway is the better estimate for an ordinary patient.

Uncertain labels change most. In the Norwegian cohort, of those first classed as indeterminate colitis or "possible IBD", 22.5% and 50% respectively were diagnosed as non-IBD at five years (Henriksen 2006). If your first report says "possible" or "suggestive of", that wording is deliberate, and follow-up is part of the diagnosis.

A pathology review captures why these changes are hard. It notes that once a pathologist has proffered a diagnosis of IBD, "it is very difficult to 'undiagnose' the condition" when a mimic is later found (Schofield 2020). Labels have momentum. That cuts both ways, and it is the main reason this article spends time on what to do when doctors disagree.

Infection: the most important look-alike in the first weeks

A first attack of UC and an acute infectious colitis can be indistinguishable on symptoms and on the scope. Biopsies are the best separator, and stool tests are mandatory, but neither is perfect in the first days.

The classic study here followed 48 people with acute self-limited colitis (the pathologist's term for colitis that clears on its own, usually infectious), 36 people in a first attack of UC and 84 with recurrent UC. Fever, abdominal pain and the time from onset to presentation did not separate them, and overall clinical and endoscopic severity were identical across the three groups. An infectious organism was identified in only 42% of the self-limited cases. What did separate them was the biopsy: plasma cells extending to the base of the lining and distorted crypt architecture were present in every UC case and absent in every self-limited case (Nostrant 1987).

That 42% matters. More than half of the infections in that study were never pinned to a named bug, so "your stool test was negative" does not prove it was not an infection.

How early can a biopsy tell?

This is where the literature disagrees with itself, and it is worth knowing because it explains why some people get "probably UC, let's see" rather than a firm answer.

• The 1987 study concluded that biopsies were only diagnostic when taken in the acute phase, "usually within the first 4 days from the onset of symptoms" (Nostrant 1987).
• A 1994 blinded study of 52 people with self-limited colitis, 51 with IBD of under three months' duration and 30 with chronic IBD concluded the opposite: biopsies were useful "even if the biopsy specimens are not obtained during the first 4 days", and chronic IBD changes were seen as early as 7 days after onset (Surawicz 1994).
• An earlier study by the same group found that one or more of the seven most discriminating features was present in 79% of IBD cases (Surawicz 1984). Turn that around and about one in five people with IBD had none of them on that biopsy.

The European guideline's synthesis is the most useful summary. Basal plasmacytosis, the earliest and most predictive feature of UC, can be found in 38% of patients within two weeks of symptoms; only about 20% show crypt distortion in that window; and widespread architectural distortion appears later, at least four weeks after presentation. Where two or three features are present, a correct UC diagnosis is reached in about 75% of cases (Maaser 2019).

The guideline also offers a clock that does not need a microscope: loose stools lasting more than six weeks usually separate IBD from most infectious diarrhoea (Maaser 2019). The US infectious diarrhoea guideline makes a similar point from the other side, recommending that non-infectious causes, including IBD and IBS, be considered when symptoms last 14 days or more without an identified source. It also notes that identifying a bacterial cause can prevent unnecessary colonoscopy, surgery "or medical treatment for suspected ulcerative colitis" (Shane 2017).

Which infections, and which tests?

For diarrhoea with fever, bloody or mucoid stool, severe cramping or signs of sepsis, the US guideline recommends stool testing for Salmonella, Shigella, Campylobacter, Yersinia, C. difficile and Shiga toxin-producing E. coli (Shane 2017). The British guideline says stool cultures and C. difficile toxin testing "should always be performed" when UC is suspected (Lamb 2019). A few details are worth knowing:

• Campylobacter is the infection with a paper literally titled "mistaken for ulcerative colitis". The case report notes that it can present with a clinical syndrome and endoscopic findings similar to acute UC (Cooper 1992).
• C. difficile is often discussed as a UC mimic, but the US guideline notes that bloody stools are "not an expected manifestation" of C. difficile infection (Shane 2017). It is tested for because it is common, especially after antibiotics, and because it also complicates existing UC.
• Modern stool PCR panels have their own trap. A pathology review points out that stool PCR "may reflect past exposure rather than an ongoing infection" (Panarelli 2023). A positive result does not automatically explain everything, and the r/UlcerativeColitis threads are full of people told "it's just the infection" whose symptoms carried on long after it was treated.
• Travel changes the list. The European guideline says testing should be tailored to history, including ova, cysts and parasites after travel abroad (Maaser 2019).

If you had food poisoning or a stomach bug before all this started, our post on IBS after food poisoning covers the post-infectious side, including the 7, 14 and 30 day clocks.

Amoebic colitis: the mimic where the wrong treatment is dangerous

Amoebic colitis, caused by the parasite Entamoeba histolytica, is the clearest example of why "just start steroids and see" is not a safe approach to new bloody colitis. A systematic review of reports from 1991 to 2016 found 24 cases of fulminant amoebic colitis linked to corticosteroids. Fourteen of them (58%) had been given steroids for an initially misdiagnosed colitis, mainly inflammatory bowel disease, and progressed rapidly. Nearly half needed surgery and 25% died, even though all eventually received anti-parasitic treatment (Shirley 2016).

The cases came from areas where amoebiasis is common or from people who had travelled to them. That is the practical point: if you have lived in or travelled to such an area, even years ago, say so before a diagnosis is made, not after it.

Sexually transmitted proctitis: the mimic nobody asks about

Inflammation confined to the rectum, called proctitis, is how a large share of UC first shows up. It is also how several sexually transmitted infections show up. US guidance lists gonorrhoea, chlamydia (including the lymphogranuloma venereum, or LGV, strains), herpes and syphilis as the most common sexually transmitted causes of proctitis, and says proctitis occurs predominantly in people with receptive anal exposure, which it defines as oral-anal, digital-anal or genital-anal contact. Of the related proctocolitis, it says: "The clinical presentation can be mistaken for inflammatory bowel disease or malignancy, resulting in a delayed diagnosis" (Workowski 2021).

This is not a theoretical risk:

• A UK series described 12 men initially investigated as IBD who turned out to have LGV proctitis. Ulcers, cryptitis, crypt abscesses and granulomas were common on biopsy, which is to say the pathology looked like IBD, and in three suspected cases LGV DNA was confirmed by going back to the stored biopsies (Soni 2010).
• A report of three cases described the diagnosis being changed when the colitis did not respond to IBD treatment, when more history emerged, when a chlamydia antibody test came back positive, or when symptoms responded to antibiotics (Gallegos 2012).
• A 2025 case report describes a man first treated for haemorrhoids, whose scope then showed ulceration that "rendered IBD a plausible diagnosis", before a rectal swab tested positive for chlamydia (Khoury 2025).

One of the higher-engagement misdiagnosis threads on r/UlcerativeColitis, titled "Attn: Gay men, Women. Ulcerative Colitis Misdiagnosis", tells this story from the patient's side: a UC diagnosis, more than a year of escalating treatment including biologics, and then positive rectal swabs for chlamydia and gonorrhoea after the poster looked up the word "proctitis" on their own report. The replies are instructive too. Some people with UC say they had never once been asked about sexual history. Others say biopsies confirmed their UC beyond doubt, and one says doctors kept attributing their symptoms to anal sex until a biopsy showed otherwise. All of those can be true. It is one story, and we cannot verify it, but it matches the published case series closely.

The practical takeaway is simple and not embarrassing to act on. If any form of receptive anal exposure is possible, rectal swabs for gonorrhoea and chlamydia (and testing for syphilis and herpes where relevant) are quick, cheap and specific. Asking for them is not an accusation against anyone, and a negative result is useful too. Our post on tenesmus in ulcerative colitis covers the other rectum-only look-alikes, including solitary rectal ulcer syndrome, radiation proctopathy and diversion proctitis, so we will not repeat that ground here.

Crohn's disease in the colon, and the "unclassified" middle

Crohn's disease can affect only the colon, and when it does, the line between it and UC can be genuinely blurry. The British guideline estimates that in 5% to 15% of IBD patients, endoscopy and biopsies "cannot distinguish between Crohn's colitis and UC", and these people are labelled IBD-unclassified (IBD-U); this is more common in children than adults (Lamb 2019).

The textbook separators are less clean than they sound:

• Rectal involvement. UC classically involves the rectum. The British guideline notes rectal sparing has been described in UC, "but more frequently patchy inflammation of the rectum may be seen in those who have been given empirical topical therapy" (Lamb 2019). In other words, suppositories or enemas started before the scope can change what the scope sees.
• Patchiness. The European guideline says patchy inflammation "is only diagnostic in untreated adult patients" (Maaser 2019).
• Granulomas. They point towards Crohn's, but the British guideline notes they are found in only about half of people with Crohn's, and that the crypt-related type of granuloma can occur in UC, diverticular inflammation and "all forms of colitis" (Lamb 2019).
• The ileum and caecum. A "caecal patch", inflammation around the appendix and backwash ileitis (inflammation spilling into the last part of the small intestine) can all occur in UC. Backwash ileitis has been reported in up to 20% of people with extensive colitis (Lamb 2019).

Treated UC can look like Crohn's

This is the part that matters most to the reader whose new doctor doubts a long-standing diagnosis. In a series of 32 people with well-established UC who had 175 follow-up scopes with biopsies, patchiness or rectal sparing appeared at some point in 19 of them (59%), and in 47 of the 175 scopes (27%). It was not tied to any specific treatment, including rectal therapy (Kim 1999). In a second series of 41 people with UC, biopsies reverted to normal at some point in 22, and the authors concluded that non-diffuse inflammation and rectal sparing "are not necessarily markers of Crohn's disease" (Kleer 1998).

How does a team settle it? For people with suspected Crohn's or unclassified colitis, the British guideline recommends dedicated small bowel imaging (Lamb 2019). The European guideline reports that small bowel capsule studies reclassified roughly a quarter of people with unclassified IBD as Crohn's (26% in one study, 25% in another), while 37% remained unclassified during follow-up (Maaser 2019). A normal capsule does not exclude Crohn's, and capsule studies carry a retention risk if a narrowing is suspected, which the guideline says should be assessed first.

Does the distinction matter if the medicines overlap? Often less than people fear day to day, and Reddit replies saying "it's not a big deal to switch" are not wrong about most medicines. But the Norwegian study authors note that correct subclassification "is important for the success of both medical and surgical therapeutic strategies" (Henriksen 2006), and it matters most if surgery is ever discussed. If you suspect your colitis behaves more like Crohn's, our guide to telling whether you are in a Crohn's flare explains how Crohn's presentations differ.

IBS: the mix-up that usually runs the other way

People search "can IBS be mistaken for ulcerative colitis", but the documented problem is the reverse: UC and Crohn's being labelled as IBS, which delays diagnosis. In UK primary care records covering 19,555 people later diagnosed with IBD, one in four had reported gut symptoms to their GP more than six months before diagnosis, and gut symptoms were recorded in 10.4% of people five years before a UC diagnosis against 5.8% of matched controls. People with a previous IBS diagnosis were less likely to receive timely specialist review (hazard ratio 0.77, 95% CI 0.60 to 0.99) (Blackwell 2021). That confidence interval sits just below 1, so the effect is real but modest and estimated with some uncertainty.

The r/UlcerativeColitis thread "Have you been misdiagnosed with IBS before learning it was UC/IBD?" is full of versions of this, including people told it was IBS for many years despite visible blood. The original poster had been told IBS after a calprotectin of 1,600 and a colonoscopy, and several replies point out that IBS does not cause inflammation. That is correct as a principle, though calprotectin can be raised by other things, as below.

The British IBS guideline sets out how this mix-up is meant to be avoided. Everyone presenting with IBS-type symptoms for the first time should have a full blood count, CRP or ESR, coeliac serology and, if they are under 45 with diarrhoea, a faecal calprotectin "to exclude inflammatory bowel disease". It also recommends a positive diagnosis of IBS only "in the absence of alarm symptoms or signs" (Vasant 2021).

Calprotectin is good at ruling IBD out in this setting. A meta-analysis modelled that a calprotectin of 40 μg/g or below meant a probability of IBD of 1% or less in people with IBS-type symptoms (Menees 2015). It is less good at ruling IBD in: the same British guideline warns calprotectin "is not specific to IBD" and can be raised in people aged 45 or over, with obesity, infection, cancer, or medicines such as proton pump inhibitors and NSAIDs (Vasant 2021). Our calprotectin guide goes into the numbers, and high calprotectin with no symptoms covers the confusing middle ground.

Who waits longest

Women appear to wait longer. In a Spanish multicentre study of 190 people with recently diagnosed IBD, the median time from symptoms to a UC diagnosis was 6.1 months in women against 2.7 months in men, and women had higher odds of being misdiagnosed along the way (odds ratio 3.0, 95% CI 1.2 to 7.4 for UC), at every level from the emergency department to gastroenterology clinics (Sempere 2023). It is a modest-sized study and the confidence interval is wide, but the direction was consistent.

For context on typical waits: a meta-analysis of 101 studies put the median time to a UC diagnosis at 3.7 months (interquartile range 2.0 to 6.7), shorter in high-income countries, and found delayed diagnosis of UC associated with higher odds of colectomy (OR 4.13, 95% CI 1.04 to 16.40) (Jayasooriya 2023). Be careful with that last figure. It comes from a small subset of studies including 1,306 people with UC, and the interval runs from barely above no effect to sixteen-fold. The same paper's pooled weighted median for UC carries a 95% interval of 1.0 to 96.0 months, which tells you how much studies differ. A separate systematic review found that three-quarters of UC studies reported a median delay of between 2 and 6 months (Cross 2023).

If you have been told "it's IBS" and something does not fit, our post on getting your doctor to take IBS seriously covers escalation routes.

Haemorrhoids, and the "it's just piles" trap

Haemorrhoids are common, they bleed, and they get blamed first. That is reasonable when the story is bright red blood on the paper with otherwise normal bowel habits. It is not reasonable when bleeding comes with urgency, frequent loose stools, mucus, night-time trips or weight loss, which haemorrhoids alone do not explain. Several people in the IBS-misdiagnosis thread above describe being told "probably an internal haemorrhoid" before a colitis diagnosis, and the LGV case report above began with haemorrhoid treatment too (Khoury 2025).

The two can also coexist, which is why "you do have haemorrhoids" is not the end of the question. Our post on how much blood in stool is normal with UC has a table of bleeding patterns and what each tends to mean.

After 50 or 60: a different list of look-alikes

From middle age onwards, several conditions that cause bloody diarrhoea become more common: ischaemic colitis (from a temporary drop in blood flow), segmental colitis associated with diverticulosis, microscopic colitis, and bowel cancer. The European guideline names segmental colitis associated with diverticula and ischaemic colitis among the differential diagnoses a pathologist has to consider (Maaser 2019). Our post on late onset ulcerative colitis covers these in detail, including why calprotectin is less useful as a screening test at that age, so we will only add the cancer referral criteria here.

The British IBS guideline reproduces the referral criteria for suspected colorectal cancer. Definite criteria include being aged 50 or over with unexplained rectal bleeding, aged 60 or over with iron deficiency anaemia or a change in bowel habit, aged 40 or over with unexplained weight loss and abdominal pain, and a positive faecal occult blood test. Under 50, rectal bleeding with abdominal pain, a change in bowel habit, weight loss or iron deficiency anaemia is listed as a probable criterion (Vasant 2021). Those are the 2015 criteria; since NICE's 2023 update, a change in bowel habit or iron deficiency anaemia at any adult age leads to a faecal immunochemical test (NICE NG12). These are referral thresholds, not a reason to assume cancer, and colitis remains far more likely at younger ages. But they explain why no one should accept a colitis diagnosis by symptoms alone. If cancer worry is driving your searching, IBS and health anxiety looks at the actual risk figures.

Medicines that cause colitis

Some medicines cause an inflammatory colitis that can look like UC. The most important current example is cancer immunotherapy with checkpoint inhibitors. In one cohort of people with melanoma treated with these drugs, 37 of 213 (17%) developed biopsy-confirmed checkpoint inhibitor colitis, and 49 of 169 (29%) in a second confirmation cohort (Grover 2020). Anyone who develops diarrhoea or bleeding during or after immunotherapy needs their oncology team to know quickly, because this is managed as a drug side effect, not as new UC.

More commonly, medicines muddy the tests rather than cause colitis outright. NSAIDs and proton pump inhibitors can raise calprotectin (Vasant 2021), and a pathology review lists drug history alongside travel and contact with infection as essential context for a pathologist trying to separate IBD from its mimics (Schofield 2020). A complete medicine list, including over-the-counter painkillers and anything recently stopped, is part of a good diagnosis. Do not stop a prescribed medicine on your own because of this; raise it with the prescriber.

Endometriosis, lupus and coeliac disease: the autocomplete questions

These three appear constantly in search suggestions. Here is what the evidence we read supports.

Endometriosis. Deep infiltrating endometriosis can cause bowel symptoms, and a 2024 review says telling pelvic endometriosis and IBD apart "may be challenging, even for expert clinicians". The two also travel together: the review cites a large Danish study in which women with endometriosis had a 50% increased risk of IBD (Fiorillo 2024). So the realistic risk is less "endometriosis mistaken for UC" and more "one of the two being missed when both are present". Symptoms that track your cycle, painful bowel movements around your period or pain with sex are worth raising with both teams. Our post on why gut symptoms get worse on your period covers the cycle overlap.

Lupus. None of the guidelines or mimic reviews we read list lupus among the common reasons UC is misdiagnosed, and we could not find evidence that it is a frequent source of confusion. If you have lupus and new bowel symptoms, that is a question for your rheumatologist and a gastroenterologist together, not something to sort out from a search result.

Coeliac disease. Coeliac disease affects the small intestine and is checked with a blood test, which is why the British IBS guideline puts coeliac serology in the first-line tests for anyone with IBS-type symptoms (Vasant 2021). It causes diarrhoea, but visible blood and urgency are not its usual picture. If a coeliac test has not been done, it is reasonable to ask, and tell the doctor if you have already cut down on gluten, because that can affect the result.

Blood tests and gene tests that claim to settle it

They do not. The European guideline's statement is unambiguous: "Genetic or serological testing is currently not recommended for routine diagnosis of CD or UC." It explains that the best available antibody tests, pANCA and ASCA, have accuracy that is "rather limited and hence ineffective at differentiating colonic CD from UC", and that although more than 250 IBD-associated genetic variants are known, testing for them "does not allow diagnosis of IBD" (Maaser 2019).

That runs against what you will read in threads. In one reply under a "misdiagnosed with UC, found out I have Crohn's" post, a parent describes a genetic test as "conclusive" that the "UC gene was activated", and another reply credits a commercial antibody panel with confirming UC. We understand why a test result feels more solid than a pathologist's judgement, but no gene test does what that reply describes, and an antibody panel can support a diagnosis without confirming it.

There is genuine research activity here. A 2026 cross-sectional study of 224 people found antibodies against a protein called integrin alphavbeta6 in 85.8% of people with UC, with 87.1% specificity against Crohn's, outperforming pANCA and ASCA (Truniger 2026). Two caveats limit how much it can help the people who most need it. The study excluded indeterminate colitis, which is exactly the group where a tie-breaker would be valuable. And 43.8% of people with Crohn's confined to the colon also tested positive, so in the hardest comparison, the test would mislabel a large share. It is promising, early, and not a reason to doubt a diagnosis made on biopsies.

"My new GI says I don't have UC." Who is right?

Possibly either. Diagnosis changes are real, and some are corrections. But a doctor meeting a well-treated patient for the first time is looking at a colon that may no longer show the features that made the original diagnosis, and two of the most-discussed threads behind this article describe exactly that conflict.

In one, a person diagnosed years earlier moved to a new gastroenterologist closer to home, was told on the basis of past records that they had been misdiagnosed, stopped their medicines as instructed, and felt much worse within months. In another, a person who had felt better for years on treatment was told by a new specialist that the old results were not conclusive and that a capsule study would decide whether to continue. The replies split between "run" and "get the scope, it might settle it", and one reply from someone who says they are a doctor with Crohn's points out that the new doctor is not the one who lives with the consequences. These are both Crohn's threads, but the reasoning applies equally to UC, and the evidence above explains why a treated colon can mislead: patchiness and rectal sparing were common in treated UC, and biopsies can return to normal (Kim 1999; Kleer 1998).

What actually helps when opinions conflict:

1. Ask what the new opinion rests on. Is it a fresh scope with biopsies, a re-read of the original slides, or a reading of old reports? A new biopsy in remission and a review of the original diagnostic biopsies answer different questions.
2. Get the original evidence. Your first colonoscopy report, the pathology report from the diagnostic biopsies, early calprotectin and stool test results, and any imaging. The British guideline notes that pathologists find it easier to separate IBD from non-IBD than Crohn's from UC, and that diagnosis "is helped greatly" by multidisciplinary review (Lamb 2019). Asking whether the original slides can be reviewed is a reasonable request.
3. Ask what alternative they suspect, and how they will test for it. "Not UC" is not a diagnosis. If they think infection, which test? If they think IBS, what explains the ulcers and the biopsy findings?
4. Do not stop or change medicine without an agreed plan. If a trial off treatment is ever proposed, it should come with a monitoring plan and a clear route back. That decision belongs to you and your team together, never to a single appointment.
5. A second opinion from an IBD-specialist team is a normal request. In the Korean referral study, the specialist centre changed 13.8% of diagnoses, and the most common change was to "not IBD" (Lee 2016). Specialist review can confirm a diagnosis as easily as overturn one.

Our guide to questions to ask your gastroenterologist about colitis includes "which colitis do I have?" as a legitimate question and how to ask it, so we will not rebuild that list here.

What separates the look-alikes: a side-by-side

What to bring and what to record

The single most useful thing you can do, whether you are mid-diagnosis or doubting an old one, is make the history easy to read. Pathologists and gastroenterologists repeatedly say the history changes the interpretation of the biopsy (Schofield 2020). Things worth having written down:

• The date symptoms started, as precisely as you can. The meaning of a biopsy depends on how many days or weeks in it was taken.
• Anything in the two months before: a stomach bug, food poisoning, antibiotics, travel and where, new medicines.
• A full medicine list, including painkillers, acid suppressants and anything stopped recently.
• Any treatment started before the first scope, especially suppositories, enemas or steroids, because these change what the scope shows.
• Sexual history, if relevant, including oral-anal or digital-anal contact. You can write it down and hand it over if saying it aloud is hard.
• Copies of every report: colonoscopy, pathology, stool tests, calprotectin and imaging, with dates.
• How you responded to each treatment, because "did not respond at all" is one of the clues that prompts a diagnosis rethink (Gallegos 2012).

Our post on what to track in an IBD symptom diary covers the ongoing log, and preparing for a GI appointment covers the one-page summary. If you would rather speak than type, Clairop lets you log symptoms and meals by voice and produces a one-page report to take to your appointment; it does not diagnose anything, but a dated record of when things started and what changed is exactly what a doctor weighing a mimic needs.

A worked example: two people, one report

This is illustrative, not a real case.

Two people in their 20s each have a colonoscopy after two weeks of bloody diarrhoea and urgency. Both reports say: "Continuous inflammation from the rectum to the sigmoid, ulceration, appearances suggestive of ulcerative colitis. Biopsies taken." Both start rectal treatment while waiting.

Person A had no recent travel, no antibiotics and no relevant exposures. Stool tests are negative. The biopsies, taken at about two weeks, show basal plasmacytosis but not much crypt distortion. The team says "likely UC" and plans a follow-up review. Over the next months, symptoms recur when treatment is reduced, calprotectin stays raised, and a later full colonoscopy with biopsies shows chronic architectural change. The diagnosis firms up with time, which is what the European guideline's timeline predicts: architectural distortion often appears only after four weeks (Maaser 2019).

Person B has the same report, but mentions on a follow-up form that symptoms started after a new sexual partner, and that no one had asked. Rectal swabs are taken and come back positive for chlamydia. After antibiotics, symptoms settle and a repeat scope is normal. Had treatment simply been escalated because the "UC" was not responding, the actual cause could have gone untreated for months, as in the published case series (Soni 2010).

Same scope report. Different histories. The history was the test that separated them.

Myths about what gets mistaken for UC

"A colonoscopy proves it's UC." The European guideline says no endoscopic feature is specific to UC or Crohn's (Maaser 2019). The scope shows inflammation; the biopsies, stool tests, timeline and response to treatment tell you what kind.

"If it were an infection, the stool test would have found it." In the 1987 study, a pathogen was identified in only 42% of self-limited colitis cases (Nostrant 1987). Tests have improved since then, but a negative stool test still reduces the chance of infection rather than excluding it.

"Most misdiagnosed UC is really Crohn's." In both adult cohorts, more people turned out not to have IBD at all than switched between UC and Crohn's (Henriksen 2006; Lee 2016).

"A blood or gene test can confirm which one I have." Not recommended for routine diagnosis, and limited at separating colonic Crohn's from UC (Maaser 2019).

"Biopsies show UC forever, even in remission." Chronic changes often persist, but in one series biopsies returned to normal at some point in 22 of 41 people with UC (Kleer 1998).

"Patchy inflammation or a spared rectum means Crohn's." Only in untreated adults, per the European guideline; treated UC is often patchy (Maaser 2019; Kim 1999).

"Starting steroids quickly is always safe if it looks like colitis." Not if it is amoebic colitis (Shirley 2016). That is why stool tests and travel history come first.

When to see a doctor promptly

See a doctor promptly, and do not wait for a routine appointment, if you have:

• Blood in your stool that is new, heavy, or comes with clots
• More than six bloody stools a day, fever, a racing heart or feeling faint
• Severe or worsening abdominal pain, or a swollen, tender abdomen
• Signs of dehydration: very little urine, dizziness on standing, confusion
• Unexplained weight loss, anaemia, or night-time symptoms that wake you
• New rectal bleeding at 50 or over, or a family history of bowel cancer or IBD
• Diarrhoea or bleeding during or after cancer immunotherapy
• Bloody diarrhoea after travel to or living in a tropical region, especially before any steroid is started

If a diagnosis is being disputed, keep taking your current treatment unless a doctor who knows your case gives you a plan to change it.

The honest bottom line

Ulcerative colitis is diagnosed by putting a pattern together and excluding the things that share it. Most UC diagnoses hold up. Of those that change, more turn out to be "not IBD" than turn into Crohn's. The look-alikes worth knowing are infection, including amoebiasis and sexually transmitted proctitis, where the wrong treatment carries real risk; Crohn's colitis, which treatment can make harder to tell apart; medicine-related colitis; and, from middle age, ischaemic, diverticular and microscopic colitis and cancer. IBS is mostly the label that delays a UC diagnosis rather than the other way round.

What separates them is usually not a new test. It is biopsies taken and read with the full story attached: when symptoms started, what came before, what treatment was given before the scope, and how you responded to it. You hold most of that story. Write it down, keep your reports, and when two doctors disagree, ask what each is basing their view on before anything changes.